Australia Veterinary Market Size, Share, Report 2026-2034
Ngày đăng: 29-04-2026 |
Ngày cập nhật: 29-04-2026
Australia Veterinary Market Overview
The Australia veterinary market is experiencing robust growth, driven by the nation's exceptionally high pet ownership rates, escalating pet humanization trends, and increasing demand for advanced animal healthcare services. Australia ranks among the world's highest pet-owning nations, with approximately 28.7 million pets across an estimated 69% of Australian households, according to RSPCA data. Dogs remain the most prevalent companion animals at 48% of pet-owning households, followed by cats at 33%. The Australia veterinary market size reached USD 2.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 9.60% during 2026-2034. Annual pet-related expenditures in Australia have soared to approximately USD 33 billion—nearly triple 2019 levels—with pet owners increasingly authorizing advanced procedures costing over USD 10,000, prompting clinics to invest in sophisticated equipment, specialist staffing, and expanded service capabilities.
The market spans two primary product categories: therapeutics and diagnostics. Therapeutics—encompassing vaccines, parasiticides, anti-infectives, and medical feed additives—hold the dominant share at approximately 60.58% in 2025, reflecting the strong demand for preventive and curative animal health treatments across both companion and livestock segments. The diagnostics segment, covering immunodiagnostic tests, molecular diagnostics, diagnostic imaging, and clinical chemistry, is registering the fastest growth trajectory as the industry shifts toward preventive, data-driven healthcare models. From an animal type perspective, the market serves dogs and cats, horses, ruminants, swine, poultry, and other species, with companion animal care driving the majority of revenue growth. The convergence of rising pet healthcare expectations, veterinary clinic consolidation, technological advancement, and supportive government biosecurity frameworks is establishing a dynamic growth environment for the Australian veterinary market through the forecast period.
Request a Business Sample Report for Procurement & Investment Evaluation: https://www.imarcgroup.com/australia-veterinary-market/requestsample
Speak to an analyst:
https://www.imarcgroup.com/request?type=report&id=28830&flag=E
???????????????????? ????????
IMARC Group is a global management consulting firm that helps companies in strategy, operations, technology, and mergers & acquisitions. We have been a trusted research partner for industry leaders, providing comprehensive market insights and strategic advisory services. Our extensive research network spans across 135+ countries, and we have assisted over 3,500 clients worldwide. We offer syndicated research reports, customized research solutions, and consulting services to help businesses make informed decisions and achieve their growth targets. With a team of over 500 analysts and consultants, IMARC Group is well-positioned to provide actionable insights and data-driven recommendations.
???????????????????????????? ????????
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-631-791-1145
The Australia veterinary market is experiencing robust growth, driven by the nation's exceptionally high pet ownership rates, escalating pet humanization trends, and increasing demand for advanced animal healthcare services. Australia ranks among the world's highest pet-owning nations, with approximately 28.7 million pets across an estimated 69% of Australian households, according to RSPCA data. Dogs remain the most prevalent companion animals at 48% of pet-owning households, followed by cats at 33%. The Australia veterinary market size reached USD 2.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 9.60% during 2026-2034. Annual pet-related expenditures in Australia have soared to approximately USD 33 billion—nearly triple 2019 levels—with pet owners increasingly authorizing advanced procedures costing over USD 10,000, prompting clinics to invest in sophisticated equipment, specialist staffing, and expanded service capabilities.
The market spans two primary product categories: therapeutics and diagnostics. Therapeutics—encompassing vaccines, parasiticides, anti-infectives, and medical feed additives—hold the dominant share at approximately 60.58% in 2025, reflecting the strong demand for preventive and curative animal health treatments across both companion and livestock segments. The diagnostics segment, covering immunodiagnostic tests, molecular diagnostics, diagnostic imaging, and clinical chemistry, is registering the fastest growth trajectory as the industry shifts toward preventive, data-driven healthcare models. From an animal type perspective, the market serves dogs and cats, horses, ruminants, swine, poultry, and other species, with companion animal care driving the majority of revenue growth. The convergence of rising pet healthcare expectations, veterinary clinic consolidation, technological advancement, and supportive government biosecurity frameworks is establishing a dynamic growth environment for the Australian veterinary market through the forecast period.
Request a Business Sample Report for Procurement & Investment Evaluation: https://www.imarcgroup.com/australia-veterinary-market/requestsample
How AI is Reshaping the Future of the Australia Veterinary Market
Artificial intelligence is revolutionizing veterinary medicine in Australia, transforming clinical workflows from reactive treatment models into predictive, data-driven wellness ecosystems. From AI-powered diagnostics and automated clinical documentation to wearable biosensors and telemedicine platforms, these technologies are improving patient outcomes, reducing practitioner burnout, and expanding access to veterinary care across urban and regional communities.- AI-Powered Diagnostic Imaging and Pathology: Deep learning algorithms are being integrated into veterinary diagnostic imaging systems to analyze radiographs, ultrasounds, and CT scans with speed and accuracy that complement clinical expertise. These AI tools detect subtle abnormalities in musculoskeletal, thoracic, and abdominal images that may be missed during time-pressured consultations, supporting earlier diagnosis of conditions ranging from fractures and tumors to cardiac disease. Australian veterinary hospitals are increasingly deploying these systems to enhance diagnostic confidence and reduce turnaround times for imaging interpretation.
- Automated Clinical Documentation with Heidi Health: AI-powered documentation platforms, notably Heidi Health, are reducing administrative burden in Australian veterinary clinics by automatically generating clinical records during consultations. Implemented in more than 140 general practices and 24 specialty hospitals as of 2025, and further expanded through integration with Greencross Vet clinics in September 2025, these systems allow veterinarians to focus more time on patient care rather than paperwork, directly addressing the workforce burnout crisis affecting approximately 42% of veterinary nurses.
- Wearable Biosensors and Predictive Health Monitoring: AI-enabled wearable devices attached to collars and harnesses are continuously monitoring vital parameters including heart rate, activity levels, sleep patterns, and temperature in companion animals. These biosensors feed data into machine learning platforms that detect early warning signs of illness—such as pain, infection, or metabolic changes—before clinical symptoms manifest. Veterinary networks are building longitudinal health datasets from these devices, enabling the industry's transition from episodic treatment to continuous, predictive wellness management.
- AI-Enhanced Telemedicine and Remote Triage: Artificial intelligence is powering telemedicine platforms that enable remote veterinary consultations, with AI triage algorithms prioritizing patient cases based on symptom severity and urgency. These systems provide pet owners in rural and regional Australia with easier access to veterinary consultation services, reducing costs associated with transportation and sedation for highly anxious patients. AI chatbots integrated into clinic websites and apps guide pet owners through preliminary assessments, directing critical cases to emergency services while managing routine inquiries efficiently.
- Precision Livestock Health Management: In the livestock sector, AI-driven health monitoring systems are being deployed across Australian cattle, sheep, and poultry operations to detect disease outbreaks, monitor feed efficiency, and optimize vaccination schedules. Computer vision algorithms analyze behavioral patterns and physiological indicators across herds and flocks, identifying sick animals before infections spread. These systems integrate with national biosecurity frameworks to support early disease detection and rapid response protocols, protecting both animal welfare and the country's valuable agricultural export industries.
Australia Veterinary Market Trends
Rapid Clinic Consolidation and Corporate Veterinary Network Expansion
One of the most transformative trends in the Australia veterinary market is the accelerating consolidation of independent veterinary practices into large-scale corporate networks backed by global private equity and strategic investors. EQT's acquisition of VetPartners, completed in January 2025, created a 267-clinic network employing more than 1,300 veterinarians across Australia and New Zealand, intensifying bargaining power with pharmaceutical and equipment suppliers while accelerating protocol standardization and digital integration across sites. UK-based CVS Group has invested approximately USD 82.5 million to secure 28 Australian veterinary sites, signaling sustained cross-border interest in Australia's fragmented clinic landscape. Meanwhile, Greencross—valued at approximately USD 3.75 billion—is evaluating an ASX relisting to unlock capital for digital health initiatives and clinic refurbishments. This consolidation wave is fundamentally reshaping the competitive dynamics of the market, enabling corporate networks to achieve economies of scale in procurement, technology deployment, and specialist recruitment that independent practices struggle to match. The trend is simultaneously driving up practice valuations and creating a more technologically sophisticated and operationally efficient veterinary services ecosystem.Rising Demand for Specialist and Premium Veterinary Services
A second defining trend is the growing demand for specialist veterinary services, driven by pet humanization and the willingness of Australian pet owners to invest in advanced medical care for their companion animals. With annual pet expenditures in Australia reaching approximately USD 33 billion and owners increasingly authorizing procedures exceeding USD 10,000, veterinary hospitals are expanding their specialist capabilities in oncology, orthopedic surgery, cardiology, dermatology, and rehabilitation medicine. This shift is prompting significant capital investment in advanced medical equipment—including MRI and CT scanners, laparoscopic surgical systems, and radiation therapy units—that were previously available only in human healthcare settings. Veterinary referral hospitals are growing in number and sophistication, with facilities in Sydney, Melbourne, and Brisbane now offering multi-disciplinary specialist teams comparable to human tertiary care institutions. The pet insurance sector is simultaneously expanding, with higher policy uptake reducing the financial barrier for pet owners to access premium veterinary services and further stimulating demand for advanced diagnostics and treatment protocols.Australia Veterinary Market Summary
- Market Size (2025): USD 2.1 Billion
- Forecast Value (2034): USD 4.9 Billion
- Growth Rate (CAGR 2026-2034): 9.60%
- Key Product Segments: Therapeutics (Vaccines, Parasiticides, Anti-Infectives, Medical Feed Additives) and Diagnostics (Immunodiagnostic Tests, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry)
- Primary Growth Drivers: Record pet ownership (28.7 million pets, 69% household penetration), rising pet humanization and premium healthcare spending, clinic consolidation and corporate network expansion, AI-driven diagnostics and digital health adoption, and government biosecurity investment
Australia Veterinary Market Growth Drivers
Record Pet Ownership and Escalating Pet Humanization Expenditures
The foundational growth driver for Australia's veterinary market is the nation's exceptionally high and still-rising pet ownership rates, combined with a cultural shift toward treating pets as family members deserving of premium healthcare. With approximately 28.7 million pets across 69% of Australian households—and dogs present in 48% and cats in 33% of pet-owning homes—the addressable market for veterinary services is extraordinarily broad. More significantly, the depth of spending per pet has transformed the market economics: annual pet outlays have soared to approximately USD 33 billion, nearly tripling since 2019. Pet owners are increasingly willing to authorize advanced diagnostic procedures, surgical interventions, and ongoing treatment protocols that were once considered exclusively human-grade medical care. This willingness to spend is prompting veterinary clinics to upgrade facilities, recruit specialist practitioners, and invest in advanced medical technology, creating a self-reinforcing cycle where improved service capabilities attract higher spending and further investment in veterinary infrastructure.Government Biosecurity Investment and Disease Surveillance Infrastructure
Government investment in biosecurity programs and disease surveillance infrastructure constitutes another critical growth driver for the Australian veterinary market. In January 2025, the Australian government strengthened national biosecurity programs aimed at improving disease surveillance and livestock health management, recognizing the critical importance of animal health to the country's agricultural export economy. These programs drive demand for veterinary diagnostics, vaccines, and anti-infective therapeutics across livestock sectors including cattle, sheep, swine, and poultry. The government's emphasis on early disease detection and rapid response protocols is accelerating adoption of advanced molecular diagnostics and immunodiagnostic testing in both field and laboratory settings. Additionally, state-level investments in veterinary training programs and regional clinic support are addressing workforce capacity constraints, while regulatory frameworks governing veterinary pharmaceutical approvals and biosecurity compliance continue to expand the scope of professional veterinary services required across both companion animal and production animal sectors.Australia Veterinary Market Segments
The Australia veterinary market is segmented across product type, animal type, and region, reflecting the diverse healthcare needs spanning companion animals to commercial livestock:- Breakup by Therapeutics: The therapeutics segment encompasses vaccines, parasiticides, anti-infectives, medical feed additives, and others. Therapeutics held an estimated 60.58% market share in 2025, driven by strong demand for preventive vaccination programs, parasite control products, and antimicrobial treatments across both companion animal and livestock sectors.
- Breakup by Diagnostics: The diagnostics segment includes immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, and others. This segment is registering the fastest growth trajectory within the market, fueled by the industry's shift toward preventive care, AI-enabled imaging interpretation, and the expansion of point-of-care testing capabilities across veterinary clinics.
- Breakup by Animal Type: The market serves dogs and cats, horses, ruminants, swine, poultry, and other animal categories. Dogs and cats represent the largest revenue-generating segment, reflecting Australia's high companion animal ownership and premium healthcare spending, while ruminants and poultry drive demand through livestock production health management and biosecurity compliance requirements.
- Breakup by Region: Regional segmentation covers Australia Capital Territory and New South Wales, Victoria and Tasmania, Queensland, Northern Territory and Southern Australia, and Western Australia. Metropolitan centers in New South Wales and Victoria concentrate the highest density of specialist veterinary hospitals and corporate clinic networks, while Queensland and Western Australia drive significant livestock veterinary demand through cattle, sheep, and poultry operations.
- Breakup by End-Use Application: Applications span companion animal healthcare, livestock production health, equine medicine, and emerging specialty sectors including veterinary oncology, orthopedics, cardiology, and rehabilitation medicine. The companion animal segment is experiencing the most rapid growth, driven by pet humanization trends and expanding pet insurance penetration that reduces financial barriers to premium veterinary services.
Australia Veterinary Market Competitive Landscape
The competitive landscape of the Australia veterinary market is undergoing rapid transformation through large-scale corporate consolidation and international investment. Key players include VetPartners (EQT), which operates a 267-clinic network with over 1,300 veterinarians following EQT's acquisition in January 2025; Greencross Vets, valued at approximately USD 3.75 billion and evaluating an ASX relisting; CVS Group, which has invested USD 82.5 million to secure 28 Australian sites; and Medigrowth Australia, which is pioneering veterinary medicinal cannabis applications. The pharmaceutical supply side features global animal health companies including Zoetis, Elanco Animal Health, Boehringer Ingelheim, and MSD Animal Health, which compete for formulary placement across corporate veterinary networks. Technology entrants such as Heidi Health are disrupting traditional clinical workflows with AI-powered documentation tools now integrated across more than 140 practices. This multi-layered competitive environment—spanning clinic operators, pharmaceutical suppliers, and digital health innovators—is driving continuous improvement in service quality, operational efficiency, and patient outcomes.Latest News and Development in the Australia Veterinary Market
- January 2025: EQT completed its acquisition of VetPartners, creating a 267-clinic veterinary network employing more than 1,300 veterinarians across Australia and New Zealand, significantly intensifying supplier bargaining power and accelerating digital integration and protocol standardization across the network.
- January 2025: The Australian government strengthened national biosecurity programs aimed at improving disease surveillance and livestock health management, expanding funding for veterinary diagnostic capabilities and early disease detection infrastructure across production animal sectors.
- February 2025: Medigrowth Australia announced the launch of Kindered, a dedicated medicinal cannabis company targeting veterinary care applications, expanding therapeutic options for companion animal pain management and chronic condition treatment alongside a crowdfunding initiative.
- August 2025: Heidi Health's AI-powered clinical documentation platform expanded to more than 140 general veterinary practices and 24 specialty hospitals across Australia, automatically generating clinical records during consultations and significantly reducing administrative burden for veterinary professionals.
- September 2025: Heidi Health further expanded its AI documentation platform through integration with Greencross Vet clinics, while industry reports highlighted increasing demand for specialized veterinary services including oncology and orthopedic surgery, with veterinary hospitals investing in advanced medical equipment and expanding specialist teams nationwide.
Speak to an analyst:
https://www.imarcgroup.com/request?type=report&id=28830&flag=E
???????????????????? ????????
IMARC Group is a global management consulting firm that helps companies in strategy, operations, technology, and mergers & acquisitions. We have been a trusted research partner for industry leaders, providing comprehensive market insights and strategic advisory services. Our extensive research network spans across 135+ countries, and we have assisted over 3,500 clients worldwide. We offer syndicated research reports, customized research solutions, and consulting services to help businesses make informed decisions and achieve their growth targets. With a team of over 500 analysts and consultants, IMARC Group is well-positioned to provide actionable insights and data-driven recommendations.
???????????????????????????? ????????
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-631-791-1145
Thông tin liên hệ
: rashi.sharma
:
:
:
:
